Reading Tip!
>To get to the fulltext easy, use the library proxy bookmarklet or activate our Pubmed url for the Get it! button!
Categories
- Acta Derm Venereol (8)
- Allergy (2)
- Am J Dermatopathol (1)
- Am J Kidney Dis (1)
- Anal Bioanal Chem (1)
- Anal Chem (1)
- Ann Med (1)
- Arch Dermatol (3)
- Arch Phys Med Rehabil (1)
- Arthritis Res Ther (1)
- Arthritis Rheum (1)
- Australas J Dermatol (1)
- BMC Proc (1)
- Br J Dermatol (50)
- Cell Tissue Res (1)
- Clin Exp Dermatol (2)
- Contact Dermatitis (51)
- Dermatol Clin (3)
- Dermatol Res Pract (1)
- Dermatol Surg (1)
- Disabil Rehabil (1)
- Discov Med (2)
- Drugs Aging (2)
- Eur J Dermatol (10)
- Eur J Immunol (1)
- Exp Dermatol (4)
- Front Immunol (1)
- Genes Immun (1)
- Genet Test Mol Biomarkers (1)
- Hum Mol Genet (1)
- Hum Mutat (1)
- Hum Pathol (1)
- Infect Immun (1)
- Inflamm Bowel Dis (1)
- Int J Dermatol (1)
- Int J Med Microbiol (1)
- Invest Ophthalmol Vis Sci (1)
- J Allergy Clin Immunol (3)
- J Am Acad Dermatol (10)
- J Clin Invest (1)
- J Clin Virol (1)
- J Cutan Pathol (3)
- J Dermatol Sci (2)
- J Dtsch Dermatol Ges (4)
- J Eur Acad Dermatol Venereol (9)
- J Hand Ther (1)
- J Immunol (1)
- J Invest Dermatol (20)
- J Med Genet (1)
- J Strength Cond Res (2)
- JAMA Dermatol (4)
- JNMA J Nepal Med Assoc (1)
- Lab Chip (1)
- Methods Mol Biol (1)
- Mol Vis (1)
- N Engl J Med (1)
- Ned Tijdschr Geneeskd (13)
- Ned Tijdschr Tandheelkd (1)
- Neth J Med (1)
- Occup Environ Med (1)
- Opt Lett (1)
- PLoS One (2)
- Qual Health Res (1)
- Regul Toxicol Pharmacol (2)
- Report (1)
- Sci Transl Med (1)
- Skin Res Technol (2)
- Trials (1)
Archives
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- July 2019
- May 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- August 2018
- April 2018
- February 2018
- January 2018
- July 2017
- June 2017
- March 2017
- February 2017
- August 2016
- July 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- April 2014
- March 2014
- February 2014
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
Contributors
Meta
Monthly Archives: January 2016
Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.
Related Articles
Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.
J Invest Dermatol. 2016 Feb;136(2):399-408
Authors: Tsuchisaka A, Numata S, Teye K, Na… Continue reading
Posted in J Invest Dermatol
Comments Off on Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.
Prevalence of Contact Allergy to p-Phenylenediamine in the European General Population.
Related Articles |
Prevalence of Contact Allergy to p-Phenylenediamine in the European General Population.
J Invest Dermatol. 2016 Feb;136(2):409-415
Authors: Diepgen TL, Naldi L, Bruze M, Cazzaniga S, Schuttelaar ML, Elsner P, Goncalo M, Ofenloch R, Svensson Å
Abstract
Population-based studies on contact allergy to p-phenylenediamine (PPD) are scarce. A cross-sectional study was performed to assess the prevalence of contact allergy to PPD and its risk factors in the general population of 5 European countries. A total of 10,425 subjects were interviewed, and a random sample (n = 2,739) was patch tested to PPD. Overall, 5,286 individuals (50.9%) reported having used hair colorants at least once in their lifetime (78% female, 20% male), and 35% had used hair colorants during the last 12 months. Hair colorant avoidance because of any skin problem during the lifetime was reported by 6%. Black henna tattoos had been used by 5.5% during their lifetime. The prevalence of PPD contact allergy was 0.8% (95% confidence interval 0.6-1.0%), with no statistically significant association with gender or hair dye use. The prevalence of PPD in black henna tattoo users was 3.2% versus 0.6% in nonusers (P < 0.001). A clinically relevant positive patch test reaction to PPD related to hair coloring products was found in 0.1% (95% confidence interval 0.0-0.2%). A significant association with PPD contact allergy was observed for subjects who had black henna tattoos in their lifetime, with an age- and gender-adjusted odds ratio of 9.33 (95% confidence interval 3.45-25.26, P < 0.001). Black henna tattoos are an important risk factor for PPD contact allergy.
PMID: 26802237 [PubMed – as supplied by publisher]
Posted in J Invest Dermatol
Comments Off on Prevalence of Contact Allergy to p-Phenylenediamine in the European General Population.
Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
Related Articles |
Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
Br J Dermatol. 2016 Jan 8;
Authors: Kock M, Coenraads PJ, Blömeke B, Goebel C
Abstract
BACKGROUND: Despite a positive patch test reaction to p-phenylenediamine (PPD) and/or toluene-2,5-diamine (PTD) many people attempt to continue dyeing their hair with products containing PPD or its derivatives.
OBJECTIVES: Investigation of elicitation reactions among PPD/PTD allergic individuals to hair dye products containing the less-sensitizing PPD-derivative 2-methoxymethyl-p-phenylenediamine (ME-PPD).
METHODS: Elicitation reactions were studied in 43 PPD/PTD allergic individuals by a 45-min pre-test with a ME-PPD containing hair dye on their forearm and upon negative result followed by exposure to subsequent hair colour treatment(s).
RESULTS: 38/43 PPD/PTD allergic individuals did not develop an elicitation reaction during the pre-test with ME-PPD containing hair dye products and were eligible for subsequent hair colour treatments. Of these 38 PPD/PTD allergic individuals 29 tolerated subsequent hair dyeing with ME-PPD containing hair dye products while 9 showed mild to moderate allergic reactions upon the first hair colour treatment.
CONCLUSIONS: Hair dye products with the less sensitizing ME-PPD were tolerated by 29/43 (67%) PPD/PTD allergic individuals throughout continued hair dyeing with an average of 9 treatments per year. Five individuals reacted upon pre-testing while only mild to moderate skin reactions occurred upon hair dyeing in 9 individuals who were not identified by the pre-test. To our knowledge this is the first study among PPD/PTD allergic individuals indicating that a negative 45 min pre-testing with a hair dye product helps to avoid severe allergic reactions. This article is protected by copyright. All rights reserved.
PMID: 26749506 [PubMed – as supplied by publisher]
Posted in Br J Dermatol
Comments Off on Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on the fragrance ingredients Tagetes minuta and T. patula extracts and essential oils (phototoxicity only) in cosmetic products.
Related Articles
Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on the fragrance ingredients Tagetes minuta and T. patula extracts and essential oils (phototoxicity only) in cosmetic products.
Regul To… Continue reading
Posted in Regul Toxicol Pharmacol
Comments Off on Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on the fragrance ingredients Tagetes minuta and T. patula extracts and essential oils (phototoxicity only) in cosmetic products.